HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) Share Price Falls 9.19% Today

Himalaya Nutravedics India Lim Share Price fell to Rs 122, down 9.19% from the previous close of Rs 134.35, while the company’s market capitalisation stood at Rs 118.31 crore. As of 21 October 2026 at 3:32:47 PM IST, the move places the stock among the day’s sharpest declines in its trading range. Univest data confirms the move itself, though no company-specific trigger has been identified. The latest Univest figures show that the decline matters because it changes the short-term price setup while leaving the valuation and business context available for closer review. For readers tracking Himalaya Nutravedics India Lim Share Price, the key questions are simple: what changed in price action, what do the fundamentals say, and how does the company sit versus healthcare peers.

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 122
Previous Close	Rs 134.35
Today's Move	-Rs 12.35 (-9.19%)
Open	Rs 134
High	Rs 134
Low	Rs 122
Market Capitalisation	Rs 118.31 crore
Market Cap Category	Micro Cap

Himalaya Nutravedics India Lim Share Price moved from Rs 134.35 at the previous close to Rs 122 during the latest session, a fall of Rs 12.35 or 9.19%. The stock opened at Rs 134 and touched a high of Rs 134 before slipping to a low of Rs 122, which is also the current price. That means the day’s movement was narrow at the top and weak through the rest of the trade, with the share price settling at the lowest point in the shown range. The company’s market capitalisation of Rs 118.31 crore places it in the Micro Cap category. For investors following Himalaya Nutravedics India Lim Share Price Today, the main point is straightforward: the share price fall is real, measurable and large enough to warrant a fresh read on the stock’s fundamentals and sector positioning.

In Univest coverage, Himalaya Nutravedics India Lim Share Price remains a price-led story first, but the next layer is whether the valuation and earnings profile justify the current level. That bridge matters because the market’s next assessment often depends on the relationship between price action and the numbers behind it.

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 118.31 crore
P/E Ratio	16.01x
P/B Ratio	2.76x
EPS	Rs 8.39
Book Value Per Share	Rs 48.69
Dividend Yield	0%

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) fundamental metrics show P/E 16.01x, P/B 2.76x. Read together, these ratios describe the company's position rather than a recommendation.

HIMALAYA NUTRAVEDICS INDIA LIM has a market capitalisation of Rs 118.31 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 16.01x, P/B at 2.76x should be read against the sector and peer benchmarks rather than as a standalone signal. According to latest Univest data, additional metrics include EPS of Rs 8.39, book value per share of Rs 48.69, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.73x, median ROE of 11.33%, median ROCE of 13.25%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	16.01x
Benchmark Median P/E	31.73x
Benchmark Average P/E	45.98x
Benchmark P/E Range	3.1x to 616.89x
Company P/B Ratio	2.76x
Benchmark Median P/B	2.76x
Benchmark Average P/B	4.11x
Benchmark Median ROE	11.33%
Benchmark Average ROE	10.14%
Benchmark Median ROCE	13.25%
Benchmark Average ROCE	13.05%
Company Market Capitalisation	Rs 118.31 crore
Benchmark Median Market Cap	Rs 771.43 crore
Benchmark Average Market Cap	Rs 13,467.03 crore

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) has a P/E ratio of 16.01x, which is below the benchmark median of 31.73x, a difference of -49.54%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,18,683.95	34.61	4.84	14.85	19.11
Divi's Laboratories	DIVISLAB	2,41,310.94	82.5	13.66	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,73,078.79	79.36	19.28	26.76	19.27
Laurus Labs	LAURUSLABS	1,11,433.99	101.92	19.76	18.31	18.2
Zydus Lifesciences	ZYDUSLIFE	1,11,022.18	24.6	4.12	19.69	21.39

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) has a P/E ratio of 16.01x compared with the displayed peer median of 79.36x. Peer multiples give relative context only, not a buy or sell view. HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) has a market capitalisation of Rs 118.31 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Himalaya Nutravedics India Lim

• Himalaya Nutravedics India Lim Share Price fell 9.19% in the latest session, which makes the move relevant for short-term price tracking.
• The stock traded between Rs 134 and Rs 122, so the day’s range shows a clear intraday shift in the share price.
• Market capitalisation of Rs 118.31 crore keeps the company in the Micro Cap category.
• P/E of 16.01 and P/B of 2.76 give the stock a valuation profile that is lower than several healthcare peers.
• EPS of Rs 8.39 and book value of Rs 48.69 provide direct fundamental reference points for Himalaya Nutravedics India Lim Share Price.

About Himalaya Nutravedics India Lim

Himalaya Nutravedics India Lim operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s listed context places it among smaller market-cap names in the healthcare space, with a Micro Cap market capitalisation of Rs 118.31 crore. In the framework visible through Univest data, Himalaya Nutravedics India Lim Share Price is tied to a business profile that investors evaluate through earnings, book value and sector comparison. The current snapshot gives a compact view of the company’s listed identity, its valuation markers and its position within a broader pharmaceutical peer set.

For readers looking at Himalaya Nutravedics India Lim Share Price, the company should be understood first as a small listed healthcare name and then through the numbers attached to it. That keeps the focus on the business and its market data rather than on speculation.

Track Himalaya Nutravedics India Lim Share Price on Univest

Use HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Readers can track Himalaya Nutravedics India Lim Share Price on Univest for live price movement, valuation ratios, market capitalisation, 52-week context and stock-specific market insights. Univest also helps place the move alongside sector benchmarks, peer comparison and company fundamentals in one view. If you are following Himalaya Nutravedics India Lim Share Price for stock news or fundamental analysis, keeping the company on your watchlist can make it easier to review each fresh update in context.

Frequently Asked Questions

What is Himalaya Nutravedics India Lim Share Price today?

Ans. Himalaya Nutravedics India Lim Share Price was Rs 122 in the latest session, down 9.19% from the previous close of Rs 134.35. The move came within a range of Rs 134 to Rs 122.

Why is Himalaya Nutravedics India Lim Share Price falling today?

Ans. Univest data confirms the move itself, though no company-specific trigger has been identified. The verified facts show a decline of Rs 12.35, with the stock moving from Rs 134.35 to Rs 122.

What does Himalaya Nutravedics India Lim Share Price tell investors?

Ans. The latest move shows a sharp intraday decline in a Micro Cap healthcare stock. Himalaya Nutravedics India Lim Share Price now needs to be read with its P/E of 16.01, P/B of 2.76 and EPS of Rs 8.39.

Is Himalaya Nutravedics India Lim expensive compared with healthcare peers?

Ans. On the displayed numbers, Himalaya Nutravedics India Lim Share Price reflects a P/E below the industry median of 31.73 and below many listed peers. Its P/B of 2.76 matches the industry median, which keeps valuation moderate.

What is the market capitalisation behind Himalaya Nutravedics India Lim Share Price?

Ans. The company’s market capitalisation stood at Rs 118.31 crore. That places Himalaya Nutravedics India Lim Share Price in the Micro Cap category and well below the same-industry median market cap of Rs 771.43 crore.

What are the key fundamental figures for Himalaya Nutravedics India Lim Share Price?

Ans. The main figures are P/E of 16.01, P/B of 2.76, EPS of Rs 8.39, book value of Rs 48.69 and dividend yield of 0. These values frame Himalaya Nutravedics India Lim Share Price.

How does Himalaya Nutravedics India Lim Share Price compare with peers?

Ans. Himalaya Nutravedics India Lim Share Price is smaller than listed healthcare peers such as Sun Pharmaceutical Industries, Divi’s Laboratories and Torrent Pharmaceuticals It also trades on a lower P/E than several of them.

Which sector and industry matter for Himalaya Nutravedics India Lim Share Price?

Ans. The stock belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That matters because Himalaya Nutravedics India Lim Share Price should be judged against same-industry valuation and profitability benchmarks, not against unrelated sectors.

Where can investors track Himalaya Nutravedics India Lim Share Price updates?

Ans. Investors can track Himalaya Nutravedics India Lim Share Price on Univest for live updates, valuation ratios, 52-week context and company news. The platform also places the stock against sector and peer benchmarks.